“I don’t feel that we can talk about gun violence in this country without talking about race,” he said. “Why do I say that? We need to look at who is harmed by gun violence and who is protected. Which stories are elevated and which are minimized.”
Getting a paper published in the New England Journal of Medicine (NEJM) is a career-crowning achievement for any medical researcher. This fall, within one week, it happened to two members of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences, both of whom also happen to be Jacobs School alumnae.
Nineteen faculty members with clinical and research experience have joined the departments of Medicine, Obstetrics and Gynecology, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, and Physiology and Biophysics.
As the holiday season kicks into high gear, Jacobs School of Medicine and Biomedical Sciences physicians and scientists have recommendations for how people can stay safe and healthy this holiday season amid some increasingly concerning signs.
For teens who have struggled with obesity, it probably sounded too good to be true: a weekly injection that could help them control their eating and lead to weight loss. But the results of the clinical trial on the drug semaglutide, released earlier this month in the New England Journal of Medicine and presented at the discipline’s major conference, Obesity Week, turned out to be better than anything the participants — or even the researchers — expected.
The request by children’s hospitals nationwide this month that the federal government declare a formal state of emergency given the surge in respiratory syncytial virus (RSV) and flu cases was no surprise to Oscar G. Gómez, MD, PhD, associate professor of pediatrics.
Kathleen E. Bethin, MD, PhD, clinical professor of pediatrics and her research team have been lauded by the Pediatric Diabetes Consortium (PDC) for their contributions to the PIONEER TEENS clinical trial sponsored by the Danish pharmaceutical company Novo Nordisk.
A Black Men in White Coats chapter has been established at the Jacobs School of Medicine and Biomedical Sciences and is named in honor of the late Jonathan D. Daniels, MD ’98, the school’s former associate director of admissions who died July 4 in a fire at his North Buffalo home.
“Your baby has a genetic disease.” It’s one of the most terrifying things that new parents can hear. Yet it frequently turns out not to be true because, while newborn screening is extremely accurate for many common conditions, screening accuracy rates for rare — even fatal — conditions can be abysmal, according to genetics specialists.
The New England Journal of Medicine published a paper Nov. 3 that described how children with high-risk Hodgkin lymphoma responded to a targeted therapy for the disease that has been effective in adults.
Steven E. Lipshultz, MD, the A. Conger Goodyear Professor and Chair of pediatrics, is co-author on a new paper that validates the long-term efficacy and safety of metabolic and bariatric surgery (MBS) for treatment of adolescent obesity.
